Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Status:
Completed
Trial end date:
2020-10-05
Target enrollment:
Participant gender:
Summary
The objective of the trial is to evaluate the efficacy of dasiglucagon administered as a
subcutaneous (SC) infusion in reducing hypoglycemia in children with CHI.